Study suggests obesity may also impact flu transmission, not just severity of illness

August 2, 2018, Infectious Diseases Society of America
H1N1 influenza virus particles. Credit: NIAID

Obesity increases a person's risk for severe complications from influenza, including hospitalization and even death. It may also play a role in how flu spreads, according to a new study published in The Journal of Infectious Diseases. The findings suggest that obese adults infected with flu shed the virus for a longer time than adults who are not obese, potentially increasing the opportunity for the infection to spread to others.

"This is the first real evidence that obesity might impact more than just disease severity," said senior study author Aubree Gordon, MPH, Ph.D., of the University of Michigan School of Public Health. "It might directly impact transmission as well."

Analyzing data collected from approximately 1,800 people in 320 households in Managua, Nicaragua, researchers investigated the effect of obesity on the duration of viral shedding over three seasons from 2015 to 2017. Obese adults with flu symptoms and laboratory-confirmed influenza shed influenza A for 42 percent longer than adults with flu who were not obese. Among infected with flu who were only mildly ill or had no symptoms, the difference was even greater: These obese adults shed influenza A virus for 104 percent longer than non- with flu.

The duration of viral shedding was determined by tests of nose and throat samples, which detected the presence of RNA but did not indicate whether the viruses were infectious. Additional research, now underway, will help determine if the flu virus shed for longer periods by obese individuals is indeed infectious and can spread the illness to others, Dr. Gordon said.

In addition, the differences seen in the duration of viral shedding were limited to influenza A viruses, one of two types of flu viruses that can cause epidemics in humans. Researchers found no association with obesity and the duration of shedding of influenza B virus, which typically causes less serious illness in adults and does not cause pandemics. Obesity also did not appear to impact the duration of viral shedding among children included in the study.

Obesity can alter the body's immune response and lead to chronic inflammation, which increases with age, in addition to making breathing more difficult and increasing the need for oxygen. These factors may help explain how obesity could affect influenza risk, severity, and transmission potential, the study authors noted.

With rates of obesity rising around the world, the new findings, if supported by future studies, suggest that may play an increasingly important role in flu transmission. In a related editorial commentary that appears with the new study in The Journal of Infectious Diseases, Stacey Schultz-Cherry, Ph.D., of St. Jude Children's Research Hospital, noted several potential implications, including increased opportunities for influenza to spread in some populations.

"It is therefore even more important to develop effective strategies to prevent and control influenza, especially in the overweight and obese population, which could be challenging because of the poor vaccine responses in this population," wrote Dr. Schultz-Cherry, who was not involved with the study. "With increasing focus on the development of a universal influenza vaccine, improved protection from influenza is on the horizon. The question remains whether these approaches will not only protect this target population, but also reduce viral shedding duration."

Explore further: Flu shot less effective for obese adults

More information: Hannah E Maier et al, Obesity Increases the Duration of Influenza A Virus Shedding in Adults, The Journal of Infectious Diseases (2018). DOI: 10.1093/infdis/jiy370

Related Stories

Flu shot less effective for obese adults

June 6, 2017
Although influenza vaccines are currently the best forms of protection to safeguard people against getting the flu, they are not effective in all cases. A study from Melinda Beck's research team at the University of North ...

Scientists create 3-D structure of 1918 influenza virus-like particles

July 11, 2018
Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs are not infectious, they show considerable promise as vaccine platforms for many viral diseases, including influenza. ...

Mucus protects airborne flu virus at all humidities

July 9, 2018
(HealthDay)—Influenza virus aerosols remain infectious at all humidity levels, according to a study published online June 7 in the Journal of Infectious Diseases.

Vaccines fail to protect obese mice from severe influenza infections

August 2, 2016
A study led by St. Jude Children's Research Hospital found that obese mice are not protected against influenza infections by vaccines that include adjuvants, raising concerns about vaccine effectiveness in obese humans who ...

Influenza A(H3N2) viruses predominate 2017-2018 season

February 16, 2018
(HealthDay)—Most influenza viruses identified in the 2017 to 2018 season are influenza A, with A(H3N2) viruses predominating, according to research published in the Feb. 16 issue of the U.S. Centers for Disease Control ...

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

Recommended for you

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

Anticancer drug offers potential alternative to transplant for patients with liver failure

August 15, 2018
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.